IL-9 promotes but is not necessary for systemic anaphylaxis

Area of Science:

• Immunology
• Allergy and Asthma Research

Background:

• Anaphylaxis is a severe allergic reaction involving IgE antibodies and mast cell degranulation.
• Interleukin-9 (IL-9), a Th2 cytokine, is known to play a role in asthma.
• The specific role of IL-9 in anaphylaxis has not been fully elucidated.

Purpose of the Study:

• To investigate the role of IL-9 in murine models of anaphylaxis.
• To determine if IL-9 influences both the sensitization and effector phases of anaphylaxis.
• To assess the necessity of IL-9 for anaphylaxis development.

Main Methods:

• Utilized IL-9-transgenic mice and wild-type mice treated with IL-9.
• Employed passive systemic anaphylaxis and passive cutaneous anaphylaxis models.
• Investigated active sensitization models using ovalbumin (OVA) immunization.
• Examined IL-9 receptor (IL-9R)-deficient mice.

Main Results:

• IL-9 administration increased susceptibility to fatal systemic anaphylaxis and elevated mast cell protease-1 levels.
• IL-9 enhanced susceptibility in both anaphylaxis-susceptible and -resistant mouse strains.
• IL-9 promoted sensitization, as evidenced by increased transfer of anaphylaxis susceptibility.
• IL-9 did not increase susceptibility in passive cutaneous anaphylaxis.
• IL-9 was dispensable for anaphylaxis development in IL-9R-deficient mice on a C57BL/6 background.

Conclusions:

• IL-9 promotes systemic anaphylaxis by acting on both sensitization and effector stages.
• IL-9 exacerbates anaphylactic reactions but is not strictly required for the process in all contexts.
• Findings highlight IL-9 as a potential therapeutic target for managing severe allergic reactions.